Stock listing
Aprea Therapeutics, Inc.
Selected listing: APRE · NASDAQ · USD · US
Aprea Therapeutics, Inc. (NASDAQ:APRE), Health Technology. Latest release Oct 5, 2026: Aprea Therapeutics to Present at October Conferences.
- Ticker
- NASDAQ:APRE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
About Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. is a public company listed under the ticker APRE, operating in the American market. Aprea focuses on developing innovative therapies, particularly in the field of cancer treatment.
Latest news from Aprea Therapeutics, Inc.
Aprea Therapeutics to Present at October Conferences
October 5, 2026
Aprea Therapeutics to Present at October Conferences
October 4, 2026
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
September 22, 2026
Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs
August 28, 2026
Aprea Therapeutics Announces Second Quarter 2026 Financial Results
August 12, 2026
Research Aprea Therapeutics, Inc.
Aprea Therapeutics, Inc. company profile
View the public company page for Aprea Therapeutics, Inc. on 6ix.
Aprea Therapeutics, Inc. news
Read company news and market updates connected to Aprea Therapeutics, Inc..
Aprea Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Aprea Therapeutics, Inc..